Recruitment

Recruitment Status
Completed

Inclusion Criterias

Patients with active diagnosis of COPD, confirmed by spirometry documented in medical notes
Patients with active diagnosis of COPD, confirmed by spirometry documented in medical notes

Exclusion Criterias

Patients who are currently receiving other maintenance therapy (except LAMA) for COPD.
Patients previously prescribed Indacaterol.
Patients who are currently receiving other maintenance therapy (except LAMA) for COPD.
Patients previously prescribed Indacaterol.

Summary

Conditions
Chronic Obstructive Pulmonary Disease
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Inclusion Criterias

Patients with active diagnosis of COPD, confirmed by spirometry documented in medical notes
Patients with active diagnosis of COPD, confirmed by spirometry documented in medical notes

Exclusion Criterias

Patients who are currently receiving other maintenance therapy (except LAMA) for COPD.
Patients previously prescribed Indacaterol.
Patients who are currently receiving other maintenance therapy (except LAMA) for COPD.
Patients previously prescribed Indacaterol.

Locations

London
London

Tracking Information

NCT #
NCT02123199
Collaborators
Not Provided
Investigators
Study Director: Novartis Pharmaceuticals Novartis Pharmaceuticals